Target-based-drug-designing|OMICS International|Drug Designing: Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Target Based Drug Designing

Pharmacophores correspond to common chemical features associated to an affinity for a specific receptor. They explain how structurally diverses ligands can bind to a common receptor site. Emerging fragments correspond to a conjunction of chemical features associated to a class of chemicals. These two notions are very close but one (pharmacophore) is based on the definition of common characteristic associated to a class of derivatives and the second (emerging fragment) is based on the comparison of chemical datasets (normally two datasets).Polypharmacological properties are associated to all molecules interacting with biological processes. The issue is to control these properties by a specific orientation towards therapeutic targets. vs Bureau R, Pharmacophores vs Emerging fragments. Analysis of polypharmacological and toxicological properties related to chemical derivatives.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on April, 2021